Therapeutic intervention in Crimean-Congo hemorrhagic fever: where are we now?

Future Virol. 2015;10(3):203-206. doi: 10.2217/fvl.14.115.

Authors

Jessica R Spengler¹, Dennis A Bente²

Affiliations

¹ Viral Special Pathogens Branch, Division of High Consequence Pathogens & Pathology, CDC, 1600 Clifton Road, Atlanta, GA 30329, USA.
² Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA ; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX 77555, USA.

No abstract available

Keywords: Bunyavirus; Crimean-Congo hemorrhagic fever; antiviral; therapeutics; treatment.

Grants and funding

CC999999/Intramural CDC HHS/United States